Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody-mediated immune response after FSME-Immun vaccination against tick borne encephalitis after hematopoietic stem cell transplantation
2014-003573-42Phase 4Completed
- Sponsor
- Region Västra Götaland
- Start
- Sep 2014
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of FSME-IMMUN in tick-borne encephalitis (TBE) (2 cohorts), sponsored by Region Västra Götaland. Primary endpoint: Post immunization titers of TBE-specific antibodies. Started Sep 2014; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2014-003573-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003573-42.